69/100
overall score
Total issues found:
148848Updated on: November 26, 2024
Data we analyse
Phishing and malware
148524
issues
Network security
9
issues
Email security
0
issues
Website security
315
issues
Recent critical risk issues we found
1023 corporate credentials stolen
313 SSL configuration issues found
Only 29% of systems cloud-hosted
Only 17% of systems CDN-protected
What information we check
Software patching
Web application security
Email security
Dark web exposure
Cybersecurity Benchmark
A comparison of this company’s cybersecurity ranking with industry averages and peer organizations
Phishing and malware
0
vs.
41
Network security
96
vs.
91
Email security
100
vs.
71
Website security
60
vs.
65
Get Your Free Report
Need help in fixing issues? Contact us and we will help you prepare an action plan to improve your risk rating.
Company overview
AbbVie (abbvie.com) is a global, research-driven biopharmaceutical company headquartered in North Chicago, Illinois. Formed in 2013 as a spin-off from Abbott (NYSE: ABBV), AbbVie discovers, develops, manufactures and commercializes specialty therapeutics across immunology, oncology, neuroscience, eye care and aesthetics, with extensive R&D and global manufacturing operations. The company markets leading medicines worldwide and partners broadly to advance patient-focused innovation.
Details
Website:
Industries:
Manufacturing
Company size:
10,001+ employees
Founded:
-
Headquarters:
1 Waukegan Road; North Chicago, Illinois 60064, US
Outcome reliability
We analyze billions of signals from publicly available sources to deliver validated insights into how your company is perceived externally by threat actors. These insights help security teams respond more quickly to risks, manage zero-day incidents effectively, and reduce overall exposure.
